CUR is a multitarget drug capable of decreasing the expression of molecules involved in angiogenesis, such as VEGF, and tumor invasion, such as intracellular adhesion molecule-1 (ICAM-1), MMP-2, and MMP-9 in CCA [308]. The gene discussed is MMP9; the disease is neoplasm.